Silence Therapeutics (SLN) Current Leases: 2019-2025
Historic Current Leases for Silence Therapeutics (SLN) over the last 7 years, with Sep 2025 value amounting to $85,000.
- Silence Therapeutics' Current Leases rose 147.06% to $85,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $85,000, marking a year-over-year increase of 147.06%. This contributed to the annual value of $117,000 for FY2024, which is 48.68% down from last year.
- Per Silence Therapeutics' latest filing, its Current Leases stood at $85,000 for Q3 2025, which was up 41.67% from $60,000 recorded in Q1 2025.
- Silence Therapeutics' Current Leases' 5-year high stood at $523,126 during Q4 2022, with a 5-year trough of -$588,096 in Q3 2022.
- For the 3-year period, Silence Therapeutics' Current Leases averaged around -$92,361, with its median value being -$206,426 (2024).
- Per our database at Business Quant, Silence Therapeutics' Current Leases tumbled by 1,243.29% in 2021 and then skyrocketed by 183.26% in 2022.
- Silence Therapeutics' Current Leases (MRQ) stood at $184,677 in 2021, then soared by 183.26% to $523,126 in 2022, then plummeted by 56.42% to $228,000 in 2023, then crashed by 48.68% to $117,000 in 2024, then dropped by 27.35% to $85,000 in 2025.
- Its last three reported values are $85,000 in Q3 2025, $60,000 for Q1 2025, and $117,000 during Q4 2024.